Submitting to HSA through SHARE and CorpPass

1. Key takeaways

All product registration and dealer licensing matters in Singapore are handled through HSA’s electronic submission system, SHARE (Singapore Health Product Access and Regulatory E-System). The prerequisites for using SHARE are: the company must first complete entity registration in Singapore, and then, through CorpPass (the Singapore Government’s corporate digital identity for entities), the entity administrator adds SHARE as an e-Service for the entity and grants access to the specific staff who will handle submissions. Because every regulatory transaction for a medical device company in Singapore passes through this one system, the account setup chain is not an IT detail — it is the gateway to the entire regulatory relationship, and it must be scheduled as seriously as the dossier itself.

• SHARE is the mandatory channel for all product registration and Dealer’s Licence transactions with HSA.
• Access depends on CorpPass, which only Singapore-registered entities can obtain — the technical root of why foreign manufacturers cannot file directly.
• The setup chain runs: Singapore entity registration (ACRA) → CorpPass activation → adding SHARE as an e-Service → granting user access → login and submission.
• The chain typically warrants a 2–4 week allowance in the project schedule, run in parallel with technical document preparation.

2. Legal basis

The requirements below come from HSA’s official descriptions of SHARE and the dealer licensing process, which together establish that the system is not optional for any regulated transaction.

These sources leave no room for alternative filing routes: whether the matter is a new registration, a licence application, a change notification or a Class A product notification, the transaction must be executed inside SHARE by an authorised user of a Singapore entity with CorpPass-linked access. In other words, the system is the single, non-negotiable interface between a dealer and HSA, and its availability, account integrity and permission hygiene directly condition the company’s ability to meet any regulatory deadline at all.

3. Expert insights

Insight 1: CorpPass is the technical root of why foreign manufacturers cannot apply on their own behalf. As discussed in Chapter 05 on the Registrant system, here is its technical-side explanation: CorpPass is the corporate digital identity system of the Singapore Government for locally registered entities. A foreign manufacturer without a Singapore entity has no CorpPass, and therefore cannot activate SHARE — this is not an administrative preference of HSA but a necessary consequence of the system design. Whoever opens the SHARE account effectively holds the initiative in the submission process. This is why the selection of the local entity that owns the account, and the contract terms governing that ownership, deserve as much attention as the choice of Registrant itself: control of the account means control of when, how and what gets filed.

Insight 2: SHARE’s scope of coverage is broader than many people assume. It is not only product registration. SHARE covers product registration applications, dealer licence applications, change notifications, product notification (Class A), and UDI-related submissions, among other transactions. Almost every regulatory action a company takes for medical devices in Singapore happens inside this system. That concentration has a practical upside — one auditable channel for the whole relationship — but also a concentration risk: if the account or its permissions fail, every parallel workstream stalls at once.

Insight 3: The activation chain is long and must be scheduled in advance. The complete chain is: Singapore entity registration (ACRA) → CorpPass activation → the CorpPass administrator adds SHARE as an e-Service → the administrator grants access to the handling staff → login and submission. Every step in the chain depends on the previous one being completed. In project scheduling we usually reserve 2–4 weeks for this chain and run it in parallel with the preparation of the product technical documentation. Waiting until the dossier is ready to start the account setup is the classic serialisation error, and it converts a routine administrative process into the critical path of the launch.

Insight 4: Permission design is part of compliance internal control. SHARE permissions are allocated by the CorpPass administrator. We advise clients: do not concentrate SHARE access on a single employee account that could leave with a resignation; separate the administrator and the handling roles; and keep records of permission changes. This is both an internal control requirement and a safeguard against submission interruptions caused by staff turnover. A periodic review of who holds which rights — ideally at each quarterly regulatory review — keeps the setup aligned with the actual organisation.

4. Practical recommendations

• Make SHARE activation step zero of the project: run it in parallel with technical document preparation, never in series.
• Confirm entity status before operating the system: the entity’s registration status and the choice of CorpPass administrator must both be settled before activation.
• Apply a two-person permission structure: at least one administrator plus one handling user, avoiding single-point dependency.
• Run a system pre-check before submission: confirm the e-Service has been added, permissions are active, and the corporate information (name, address, UEN) matches the content to be submitted.

5. Verification checklist

• □ The Singapore entity has completed registration
• □ CorpPass has been activated and the administrator designated
• □ SHARE has been added as an e-Service of the entity
• □ Handling staff have been granted SHARE access
• □ The permission setup meets the two-person internal control requirement
• □ Corporate information matches the content to be submitted
• □ SHARE activation has been built into the project schedule (with a 2–4 week allowance)

Regulatory information verified as of: 26 October 2026

Source level: Tier 2 (HSA Quick Guide, HSA dealer licence application page, HSA SHARE page)

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Singapore. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with HSA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com